The INCIVEK brand, founded in 2011 (United States), from
18 sister brands
and 2214 competing brands.
INCIVEK is owned by Vertex Pharma, listed on the stock exchange of New York
INCIVEK belongs to the Biotechnology business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.